Table 2.
Study | Study design | Syndrome | Intervention and comparison groups | Outcome measure | Participants | Age range | Setting | Country (continent) | Reported effect |
McCollum et al32 | Retrospective secondary analysis of prospective cohort study data | Pneumonia | PO+IMCI vs PO+Malawi guideline 2000 vs IMCI35 vs Malawi guideline 200036* | Missed eligibility for referral to hospital | 14092 children with pneumonia | 2–59 months | 18 rural health centres and 38 village clinics | Malawi (Africa) | At rural health centres, IMCI resulted in 390/938 (41.5%) missed eligible referrals and Malawi guideline 2000 in 143/1761 (8.1%) if PO not used At village clinics, both IMCI and Malawi guideline 2000 resulted in 52/990 (5.3%) missed eligible referrals if PO not used |
Hooli et al29 | Retrospective secondary analysis of prospective cohort study data | Pneumonia | PO+IMCI vs PO+Malawi guideline 2000 vs IMCI35 vs Malawi guideline 200036* | Missed eligibility for referral to hospital | 261 infants with cough and/or shortness of breath | <2 months | 18 rural health centres | Malawi (Africa) | IMCI resulted in 1/238 (0.4%) missed referral if PO not used, and Malawi guideline 2000 1/236 (0.4%) If hypoxaemia was defined as SpO2 <93%, IMCI resulted in 2/238 (0.8%) missed referral if PO not used, and Malawi guideline 2000 4/236 (1.7%) |
Tesfaye et al31 | Parallel cluster-randomised trial | Pneumonia | PO+IMCI vs IMCI35* | Referral to hospital | 1804 children with cough or difficulty breathing <14 days | 2–59 months | 24 rural primary health centres | Ethiopia (Africa) | 116/148 (78.4%, 95% CI 67.6 to 89.2) referred in PO+IMCI group vs 15/34 (44.1%, 95% CI 6.9 to 81.3) in IMCI group, p=0.496 |
Sylvies et al23 | Uncontrolled before-and-after study | Non-malarial fever | PO+IMCI vs IMCI35 vs Malawi guideline 2019 vs Malawi guideline 2016*† | Antibiotic prescription | 3504 children with non-malarial fever | 0–59 months | Five mobile rural health clinics | Malawi (Africa) | 336/795 (42.2%) prescribed antibiotics in PO+IMCI group vs 150/178 (84.2%) in IMCI group vs 485/571 (84.9%) in Malawi guideline 2019 group vs 1461/1960 (74.5%) in Malawi guideline 2016 group, p<0.001 OR for reduced antibiotic prescription in PO+IMCI group vs IMCI group 7.3 (95% CI 4.8 to 11.4); vs Malawi guideline 2019 group 7.9 (95% CI 6.1 to 10.5); vs Malawi guideline 2016 group 4.0 (95% CI 3.3 to 4.7) |
All interventions incorporating pulse oximetry included a staff training component. Hypoxaemia was defined as peripheral oxygen saturation (SpO2) <90% unless indicated otherwise.
*Intervention groups with pulse oximetry included a staff training component on the use of pulse oximetry.
†Hypoxaemia defined as SpO2 <95%.
IMCI, WHO Integrated Management of Childhood Illness guideline 2014; PO, pulse oximetry.